You don’t spend almost 30 years as the undisputed expert in long-term cryostorage without gathering a treasure trove of information on the subject. In our extensive bank of articles, blogs, and FAQ’s, you’ll find everything you would want to know about fertility preservation and long-term cryostorage.
Please take a moment to search our blog and articles for any information you may need. If you can’t find it there, your questions may be answered in our FAQ section. In the event that you can’t find what you’re looking for there, please get in touch with us. We’re here to help!
ReproTech’s new Scientific Advisory Board will focus on reinforcing the company’s dedication to upholding the highest safety and compliance standards in the cryostorage industry. The Board will provide expert guidance on best practices, regulatory requirements, and innovative approaches to ensure that ReproTech remains the leader in the cryostorage space. This initiative underscores ReproTech’s commitment to protecting the integrity of stored reproductive tissues and maintaining the trust of its clients.
In recognition of Breast Cancer Awareness Month, we’re honored to share Megan’s fertility preservation journey and her decision to trust ReproTech as the long-term cryostorage partner for her precious eggs. Here’s her story:
ReproTech, the industry leader in human reproductive tissue cryogenic storage, has appointed Brad Senstra as Chief Executive Officer. Mr. Senstra brings to ReproTech more than 16 years of experience in fertility and reproductive medicine. Before accepting this position, he served as Executive Director of Seattle Reproductive Medicine (“SRM”). Mr. Senstra is a noted thought leader in reproductive medicine and has presented at numerous American Society for Reproductive Medicine meetings and events over the past 16 years. He also served on the Association of Reproductive Managers Board from 2014-2017. Mr. Senstra earned his Master's of Health Administration from the University of [Read More...]
We at ReproTech are aware of the need for improved access to preserving fertility before cancer treatment and have long partnered with oncologists nationwide to provide an avenue of affordable and safe cryostorage for their patients’ reproductive specimens. Research shows that patients facing fertility-threatening treatments and thus at risk for infertility must be educated about the chances early in treatment planning. UPMC-Magee’s study, published in March 2023, is one of many studies showing a critical need for improved access to fertility preservation for all who want to have a future family following disease recovery.
For active-duty military personnel preparing for deployment, storing frozen eggs or
sperm can be a valuable way to protect future family-building options. Deployment,
especially in combat zones, may carry an increased risk of infertility, and cryostoring
eggs or sperm before deployment offers a proactive approach to safeguarding fertility.
ReproTech specializes in long-term cryostorage of human reproductive tissues (embryos, oocytes, semen, testicular/ovarian tissues). Here we answer commonly asked questions about shipping and storing these tissues with ReproTech.
We specialize in the cryostorage of human reproductive tissues. You may wonder how long an embryo can be frozen and remain viable after so many years. How are embryos frozen, and do they result in a pregnancy as often as a fresh embryo? And last, how does ReproTech fit into the family-building journey? We’re here to give you a quick overview!
The American Society for Reproductive Medicine (ASRM) announced its 2022 awards. We are excited to see that a ReproTech’s Medical Advisory Committee member, Kyle Orwig, Ph.D., will be the recipient of the ASRM Distinguished Researcher Award! This award is given for "outstanding contributions to clinical or basic research in reproduction published during the previous ten years.” Dr. Orwig oversees the UPMC Fertility Preservation Program and the UPMC Magee Center for Reproduction and Transplantation. UPMC's fertility preservation program freezes testicular and ovarian tissue for children and adults before beginning fertility-threatening treatments, or for transgender individuals, before beginning gender-affirming hormone therapy. One area [Read More...]
We’ve launched a new customer portal for an easy, streamlined experience. Invitation emails to existing customers will be rolled out in phases between March 19th and June 30th.
Thank you!